typical overpromise and underdeliver.... going from stable biotech to speculative bust..
what garbage CEO? hope we get Allergan' Brent Saunders to acquire Biogen and fire the management team..
at 220 market value~$87b..
even taking into account zero value for pipeline.. it is undervalue on pure existing business...i am not even including other business that they have acquired...once debt is reduce post Q2.. this will fly.
the current CEO typically creates hypes and then under-delivers...
investors won't wait for 2019 for alzheimer's if it all is positive.... they need to start acquiring companies NOW...
else market will keep on shrinking PE multiple....look no further than Gilead..it needs growth
yes, perfect short
Great company, but irrational price..
Buy health care stocks....will go after election is over..
if market can take gilead to P/E of 8, this can go down to 200-220.... will jump back once see some price stablization..
true....they are killing medical innovation... ,most of the companies especially small biotech will run our of equity/capital to fund..which will impact research.. wait until they get uncurable cancer!!!....bloody dem·a·gogue
Spoke Friday evening with investor analyst@KMI .. Announce plans for 2016.. Dividend will be frozen , possible some asset sales ..in my view KMI should stabling in low 20s if oil remains in this range..
Remember it was $90 stock in Nov-Dec2014 before Biomarin acquired this useless drug..sales of other drugs have gone up and pipeline advance, so at this point, market is accounting for Zero probability of approval.
Biomarin will trade with IBB biotech index going fwd...it is like 40% down from its summer highs..
I won't be short this stock at this price. mid-90s...not much downside. always a chance of M&A and surprise. it can rip upwards..
BOA Merrill Positive on results..
are u listening to conf call?.. they might have cure for MS with anti-lingo........................
as investor have time frame for few months... when market sells.. quality companies with earnings growth $7.2 eps in FY16 will hold..then go up..
Today all short term money cap out..its call PROFIT BOOKING...same short term money will be back..u can also buy AET and ANTM.. way undervalued
yeah...dem's can't be seen as negative to biotech end of the day...they represent innovation, progressive new economy,,
sanders is socialist,..when these politicians have cancer,,they will need all these medical innovations....
or computer algorithsm
...5 out of 100 go past phase 3 .....
Hillary Clinton are u listening..?